See also this year's filing and all EDGAR filings for this company.
PDF Report 0001461993_2019_Melinta_Therapeutics_INC_NEW.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001461993, Melinta Therapeutics INC NEW
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,482,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 229,196,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,586,000 |
| 3 | remainder_Assets | 61,326,000 |
| 4 | LiabilitiesCurrent | 133,606,000 |
| 5 | LiabilitiesNoncurrent | 117,920,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 41,057,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 479,303,536 |
| 9 | ResearchAndDevelopmentExpense | 53,434,182 |
| 10 | remainder_Expenses | 25,088,000 |
| 11 | remainder_Revenues | 408,976,325 |
| 12 | remainder_NetIncome | 13,255,873 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 441,590,000 |
| 1 | Liabilities | 251,526,000 |
| 2 | Expenses | 598,882,718 |
| 3 | Revenues | 408,976,325 |
| 4 | StockholdersEquity | 190,064,000 |
| 5 | NetIncome | -176,650,520 |
| 6 | ComprehensiveNetIncome | -176,650,520 |
| 7 | BaseVar | 857,115,458 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.686 |
| 9 | EconomicCapitalRatio | 2.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
